Powell Investment Advisors LLC Has $238,000 Stock Holdings in UiPath Inc. (NYSE:PATH)

Powell Investment Advisors LLC trimmed its holdings in shares of UiPath Inc. (NYSE:PATH) by 35.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,490 shares of the healthcare company’s stock after selling 5,700 shares during the period. Powell Investment Advisors LLC’s holdings in UiPath were worth $238,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the company. 180 Wealth Advisors LLC lifted its stake in UiPath by 7.2% in the 1st quarter. 180 Wealth Advisors LLC now owns 202,637 shares of the healthcare company’s stock valued at $4,594,000 after purchasing an additional 13,687 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in UiPath by 15.3% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 30,479 shares of the healthcare company’s stock valued at $691,000 after purchasing an additional 4,039 shares during the last quarter. TrueMark Investments LLC lifted its stake in UiPath by 13.5% in the 1st quarter. TrueMark Investments LLC now owns 61,259 shares of the healthcare company’s stock valued at $1,389,000 after purchasing an additional 7,306 shares during the last quarter. Future Financial Wealth Managment LLC bought a new position in shares of UiPath during the first quarter worth approximately $73,000. Finally, Sunbelt Securities Inc. increased its holdings in shares of UiPath by 7,602.5% during the first quarter. Sunbelt Securities Inc. now owns 18,178 shares of the healthcare company’s stock worth $412,000 after purchasing an additional 17,942 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on PATH. Barclays lowered their target price on shares of UiPath from $25.00 to $16.00 and set an “equal weight” rating on the stock in a report on Thursday, May 30th. TD Cowen reissued a “hold” rating and issued a $17.00 price objective (down from $28.00) on shares of UiPath in a research note on Thursday, May 30th. Evercore ISI cut their target price on shares of UiPath from $27.00 to $13.00 and set an “in-line” rating on the stock in a research report on Thursday, May 30th. KeyCorp restated a “sector weight” rating on shares of UiPath in a research report on Thursday, May 30th. Finally, Canaccord Genuity Group cut their price target on shares of UiPath from $30.00 to $19.00 and set a “buy” rating on the stock in a report on Friday, May 31st. Sixteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $18.06.

UiPath Price Performance

UiPath stock remained flat at $12.68 during midday trading on Friday. 13,004,473 shares of the company traded hands, compared to its average volume of 9,938,457. UiPath Inc. has a 1-year low of $11.07 and a 1-year high of $27.87. The company has a market capitalization of $7.26 billion, a PE ratio of -79.06 and a beta of 0.85. The stock’s 50-day simple moving average is $16.30 and its 200-day simple moving average is $20.89.

UiPath (NYSE:PATH) last released its quarterly earnings results on Wednesday, May 29th. The healthcare company reported ($0.03) earnings per share for the quarter, hitting the consensus estimate of ($0.03). UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The business had revenue of $335.11 million for the quarter, compared to analysts’ expectations of $332.84 million. As a group, analysts predict that UiPath Inc. will post -0.2 EPS for the current year.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.66, for a total value of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares in the company, valued at $14,312,104.92. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 22.37% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.